MMP13 and Bartsocas-Papas syndrome 1: The significant decrease in the urinary NGF, MMP-13, and VEGF levels and the increase in PDGF-AB level after repeated PRP injections in patients with GRA ≥ 2 provide evidence of the therapeutic efficacy in patients with IC/BPS.